 Scrip Deals Patient-reported outcomes should be considered when evaluating the benefits and risks of a device indicated for weight loss, the US Food and Drug Admission says in a new final guidance document . The 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. | 
